Mental health needs have multiplied. Support hasn't. Until now.

Woebot, the behavioral health copilot, is an enterprise solution that aims to increase access to mental health support and improve your business outcomes

When it comes to AI and mental health, our Founder and President Alison Darcy has always advocated for the need to proceed with humility, guardrails and good science. You can hear that and more in her interview with Jon LaPook on 60 MINUTES. We need balanced conversations like this one to focus AI's potential on helping humanity, because as Ali says, "We have an opportunity to develop these technologies more thoughtfully, and I hope we take it."

For the second year in a row, Woebot Health has been recognized by the 2024 MedTech Breakthrough Awards. The Mental Health Innovation Award recognizes the excellence and innovation of Woebot, which aims to offer tools and insights with the goal of enhancing the care experience, automating the collection of population insights and increasing provider efficiency, and of Woebot, the digital companion at the heart of our copilot

We were honored to be included in Newsweek’s inaugural list of the World’s Best Digital Health Companies, which recognizes stand-out companies with truly beneficial products

Woebot Health Founder, Alison Darcy, Named to 2023 TIME100 AI List, Recognizing the 100 Most Influential Individuals Advancing Artificial Intelligence

Behavioral health, at scale

Woebot is designed to help the unsolved problems in behavioral health. It aims to:

  • Address: increase equitable access and improve patient/member experience through always available mental health support
  • Activate: drive activation and overall satisfaction among your populations with multi-channel engagement campaigns and a configurable deployment strategy
  • Capture: deliver population health insights, engagement and satisfaction measures through an analytics dashboard, Spotlight
  • Impact: leverage population health measures with the goal of influencing quality scores
Quintuple aim visualQuintuple aim visualQuintuple aim visual

Woebot Health Platform is the foundational development platform where components are used for multiple types of products in different stages of development and enforced under different regulatory guidances

Built for accessibility and impact

24 %

reduction in overall work impairment1

Woebot Health analysis

24 %

reduction in burnout2

Woebot Health analysis

75 %

of messages are sent on weekends or outside of traditional working hours (9-5), with the longest 'sessions' happening between 2-5am*

Woebot Health analysis

Woebot for Mood & Anxiety (W-MA-02) is an investigational medical device. It has not been evaluated, cleared, or approved by the FDA. Not for use outside an IRB-approved clinical trial. Results are based on self-reported survey response and were all collected at 8-weeks end-of-treatment in the study. 1N = 91 internal analysis 2N = 234 internal analysis

 

*Platform data as of June 2024

How Woebot works

Woebot is available for in-the-moment mental health support, delivered through an app on a phone or tablet that can:

  • be used as a wellness support tool or clinically adjunctive support tool
  • provides user-directed, always available, interactive conversations and tools
  • encourage healthy lifestyle choices, which may help individuals live well with symptoms of anxiety and depression

Through conversations, Woebot helps users develop skills for emotional regulation and supports mood monitoring and management, with tools such as:

  • mood tracking
  • progress reflection
  • gratitude journaling
  • mindfulness practice

Woebot is not generative AI like ChatGPT. It’s rules-based. Woebot’s conversations are written by conversational writers using elements from Cognitive Behavioral Therapy (CBT), Interpersonal Psychotherapy (IPT) and Dialectical Behavioral Therapy (DBT), along with collaboration from our clinical experts. 

Available now, non-prescription:

  • Woebot for Adults: A tool to help people develop coping skills for symptoms of anxiety and depression
  • Woebot for Adolescents: A tool built for an adolescent’s (13-17 year old) dynamic and actively developing mind

Woebot for Adults and Woebot for Adolescents are not evaluated, cleared or approved by the FDA. They may be considered as an adjunct to clinical care; they do not replace clinical care. 

Population Insights

Spotlight, our data analytics platform, and team aggregates insights from Woebot, including: 

  • Patient/member top focus areas and concerns
  • Quality measure scores
  • SDOH insights
  • Engagement and satisfaction measures
  • Concerning language recognition*

With the goal of automating measurement capture for clinicians and increasing visibility beyond the traditional four walls of care. 

Image of Spotlight dashboard and user conversationImage of Spotlight dashboard and user conversationImage of Spotlight dashboard and user conversation

Image(s) of the Spotlight Dashboard are an example of an implementation for adjunctive use. Woebot Health Platform is the foundational development platform where components are used for multiple types of products in different stages of development and enforced under different regulatory guidances.

*Woebot does not provide crisis counseling and is not a suicide prevention or crisis intervention service. Concerning language is not reviewed or assessed internally at Woebot Health in real-time for intervention and such data is not used for managing potential crises or any acute or non-acute patient safety issue. Discomfort may be experienced when answering sensitive questions. Temporary upset may occur as a result of discontinued access.

Connect with us

Together, we can build a more accessible, equitable, and effective system that prioritizes the well-being of individuals and communities.


Achievements

ORCHA does not follow the Federal Food, Drug, and Cosmetic Act and therefore ORCHA certification does not denote clearance or approval by the U.S. Food and Drug Administration (FDA).